Latest news
Atea’s hep C pill equal to Gilead’s; AbCellera inks second deal in two months - Endpoints NewsEndpoints News · Wed, 29 Jul 2026 07:00:00 GMTAtea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus - Yahoo! Finance CanadaYahoo! Finance Canada · Tue, 28 Jul 2026 07:00:00 GMT